Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil Lou

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
Journal for Immunotherapy of Cancer|June 20, 2018
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinomaEvidio Domingo-Musibay, Paari Murugan, Alessio Giubellino, et al.
Cancer Biology & Therapy|July 23, 2019
UNC-45A is preferentially expressed in epithelial cells and binds to and co-localizes with interphase MTsJuri Habicht, Ashley Mooneyham, Mihir Shetty, et al.
Frontiers in Cell and Developmental Biology|October 19, 2018
Cellular and Molecular Networking Within the Ecosystem of Cancer Cell Communication via Tunneling NanotubesEmil Lou, Edward Zhai, Akshat Sarkari, et al.
Cancers|October 14, 2022
TNTdetect.AI: A Deep Learning Model for Automated Detection and Counting of Tunneling Nanotubes in Microscopy ImagesYasin Ceran, Hamza Ergüder, Katherine Ladner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastomaEmil Lou, Scott Turner, Ashley Sumrall, et al.
JCO Oncology Practice|June 24, 2020
Reply to S. Boutayeb et alEmil Lou, Muhammad Shaalan Beg, Emily Bergsland, et al.
American Journal of Clinical Oncology|August 28, 2020
Cancer Management During the COVID-19 Pandemic in the United States: Results From a National Physician Cross-sectional SurveyJane Yuet Ching Hui, Jianling Yuan, Deanna Teoh, et al.
Plos One|March 20, 2012
Tunneling nanotubes provide a unique conduit for intercellular transfer of cellular contents in human malignant pleural mesotheliomaEmil Lou, Sho Fujisawa, Alexei Morozov, et al.
Plos One|November 24, 2020
Emotional health concerns of oncology physicians in the United States: Fallout during the COVID-19 pandemicLauren Thomaier, Deanna Teoh, Patricia Jewett, et al.
Cancer Research Communications|September 9, 2022
GLS1 is a protective factor in patients with ovarian clear cell carcinoma and its expression does not correlate with ARID1A-mutated tumorsValentino Clemente, Asumi Hoshino, Mihir Shetty, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Journal for Immunotherapy of Cancer|June 20, 2018
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinomaEvidio Domingo-Musibay, Paari Murugan, Alessio Giubellino, et al.
Cancer Biology & Therapy|July 23, 2019
UNC-45A is preferentially expressed in epithelial cells and binds to and co-localizes with interphase MTsJuri Habicht, Ashley Mooneyham, Mihir Shetty, et al.
Frontiers in Cell and Developmental Biology|October 19, 2018
Cellular and Molecular Networking Within the Ecosystem of Cancer Cell Communication via Tunneling NanotubesEmil Lou, Edward Zhai, Akshat Sarkari, et al.
Cancers|October 14, 2022
TNTdetect.AI: A Deep Learning Model for Automated Detection and Counting of Tunneling Nanotubes in Microscopy ImagesYasin Ceran, Hamza Ergüder, Katherine Ladner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastomaEmil Lou, Scott Turner, Ashley Sumrall, et al.
JCO Oncology Practice|June 24, 2020
Reply to S. Boutayeb et alEmil Lou, Muhammad Shaalan Beg, Emily Bergsland, et al.
American Journal of Clinical Oncology|August 28, 2020
Cancer Management During the COVID-19 Pandemic in the United States: Results From a National Physician Cross-sectional SurveyJane Yuet Ching Hui, Jianling Yuan, Deanna Teoh, et al.
Plos One|March 20, 2012
Tunneling nanotubes provide a unique conduit for intercellular transfer of cellular contents in human malignant pleural mesotheliomaEmil Lou, Sho Fujisawa, Alexei Morozov, et al.
Plos One|November 24, 2020
Emotional health concerns of oncology physicians in the United States: Fallout during the COVID-19 pandemicLauren Thomaier, Deanna Teoh, Patricia Jewett, et al.
Cancer Research Communications|September 9, 2022
GLS1 is a protective factor in patients with ovarian clear cell carcinoma and its expression does not correlate with ARID1A-mutated tumorsValentino Clemente, Asumi Hoshino, Mihir Shetty, et al.
Pageof 19